Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Jul;7(4):e240318.
doi: 10.1148/rycan.240318.

Comparison of Digital Breast Tomosynthesis and Mammography-based Radiomics for Breast Cancer Risk Assessment: Case-Control Study

Affiliations
Comparative Study

Comparison of Digital Breast Tomosynthesis and Mammography-based Radiomics for Breast Cancer Risk Assessment: Case-Control Study

Alex A Nguyen et al. Radiol Imaging Cancer. 2025 Jul.

Abstract

Purpose To compare the performance of volumetric radiomic parenchymal pattern analysis from three-dimensional (3D) digital breast tomosynthesis (DBT) images with that of two-dimensional (2D) digital mammography (DM) and 2D sections from DBT in assessing breast cancer risk relative to breast density measurements. Materials and Methods This was a retrospective matched case-control study among individuals who underwent concurrent DM and DBT screening from March 2011 through December 2014. The Cancer Phenomics Toolkit was used to calculate radiomic features from craniocaudal and mediolateral oblique views in all study patients, matched on race and age, for various experimental settings, including image resolution and window size. For each image type, conditional logistic regression evaluated the association of radiomic features, along with age, body mass index (BMI), and area percent density (PD) (from the Laboratory for Individualized Breast Radiodensity Assessment software), with breast cancer, using the C statistic as the measure of model predictive ability. Model fit was compared via likelihood ratio tests. Results The study included 924 female patients (median age, 61 years [IQR: 51-69 years]), with 187 cases and 737 controls. Volumetric features from 3D reconstructed DBT scans had, on average, higher C statistics across all experimental conditions. Among models using only radiomic features, C statistics were highest for models using features from 3D images (mean C statistic: 0.68, P < .001); models using features from 2D image types resulted in lower mean C statistics (0.60 to 0.65). A baseline model using age, BMI, and area PD had a C statistic of 0.60. The effect of higher image resolution and smaller window size were not substantial, supporting the use of less computationally intensive processing. Conclusion Fully automated 3D parenchymal analysis from DBT improved breast cancer risk estimation beyond markers derived from area breast density and 2D images. Keywords: Mammography, Tomosynthesis, Breast, Volume Analysis Supplemental material is available for this article. © RSNA, 2025.

Keywords: Breast; Mammography; Tomosynthesis; Volume Analysis.

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: A.A.N. No relevant relationships. E.A.C. No relevant relationships. O.H.M. Author has been working in industry since leaving the lab: 2 years at Tempus AI and 2 years at Picture Health; stock or stock options in Tempus AI and Picture Health. R.J.A. Author is an inventor named on four active patents (US9743891B2, US11185294B2, US11517270B2, and US11786186B2) and one pending patent (US20230240625A1), all patents and patent applications have been assigned jointly to Real Time Tomography and the University of Pennsylvania, none of the patents have been licensed or optioned to an outside organization; Analogic Canada provided the X-Ray Physics Laboratory with an LMAM3-DS85 x-ray detector, provided for next-generation tomosynthesis research through a material transfer agreement between the Trustees of the University of Pennsylvania, on behalf of Raymond J. Acciavatti and Andrew D.A. Maidment, and Analogic Canada. L.P. No relevant relationships. W.C.M. No relevant relationships. C.G.S. No relevant relationships. S.W. No relevant relationships. C.M.V. Grants from the National Cancer Institute and the Mayo Clinic Cancer Center to the author’s institution. A.D.M. Support for attending meetings and/or travel from AI4Imaging 2023 and 2024, University of Maastricht; patents: (a) Kontos D, Bakic PR, Maidment ADA: System and Method for Assessing Cancer Risk, U.S. patent 8,634,610, published January 21, 2014, application US-2009/0324049-A1 published December 31, 2009, application 12/488,871 filed June 22, 2009, (b) Maidment ADA, Acciavatti RJ, Bakic PR, Ng S, Ringer PA, Kuo J: Super-Resolution Tomosynthesis Imaging Systems and Methods, U.S. patent 9,743,891-B2 published August 29, 2017, application US-2015/0201890-A1 published July 23, 2015, application 14/413,279 filed July 9, 2013, U.S. PCT/US13/049789 filed January 7, 2015, world PCT WO2014/011681 filed January 16, 2014, provisional applications 61/669,459 filed July 9, 2012 and 61/763,310 filed February 11, 2013, (c) Maidment ADA, Acciavatti RJ, Ng S, Ringer PA, Kuo J: Super-Resolution Tomosynthesis Imaging Systems and Methods, U.S. patent 11,185,294-B2 published November 30, 2021, application US-2017/0245810-A1 published August 21, 2017, application 15/443,737 filed February 27, 2017, provisional application 62/300,290 filed February 26, 2016, (d) Maidment ADA, Popov AV, Delikatny J, Tsourkas A, Karunamuni R. Al Zaki A, Gavenonis S, Cormode D: Radiographic contrast agents for temporal subtraction and dual-energy x-ray imaging, U.S. patent 11,337,665-B2 published May 24, 2022, application US-2016/0038111-A1 published February 11, 2016, application 14/776,232 filed March 13, 2014, U.S. PCT/US2014/025769 filed September 14, 2014, world PCT WO2014/151454 filed September 25, 2014, provisional application 61/788,891 filed March 15, 2013, (e) Maidment ADA, Lee B, Ng S, Ringer PA, Kuo J, Acciavatti RJ: Dynamic Four-Dimensional Contrast Enhanced Tomosynthesis, U.S. patent 11,517,270-B2 published December 6, 2022, application 2016/0302742A1 published October 20, 2016, application 15/101,668 filed June 3, 2016, U.S. PCT/US2014/068610 filed December 4, 2014, world PCT WO2015/126504 filed August 27, 2015, provisional application 61/911,761 filed December 4, 2013,(f) Maidment ADA, Acciavatti RJ, Ng S, Ringer PA, Kuo J: Super-Resolution Tomosynthesis Imaging Systems and Methods, U.S. patent 11,786,186-B2 published October 17, 2023, application US-2022/0160312-A1 published May 26, 2022, application 17/535,131 filed November 24, 2021, continuation of application 15/433,737, filed February 27, 2017, now patent 11,185,294; pending patent applications: (a) Maidment ADA, Acciavatti RJ, Ng S, Ringer PA, Kuo J: Improved Super-Resolution Tomosynthesis Imaging Systems and Methods, application US-20170245810-A1 published on August 31, 2017, application 15/443,737 filed February 27, 2017, provisional application 62/300,290 filed February 26, 2016, (b) Cormode DP, Maidment ADA, Naha PC, Karunamuni R: Radiographic Nanoparticle Contrast Agents for Dual-Energy X-ray Imaging and Computed Tomography Scanning and Methods of Using Thereof, application US-2018/0236106-A1 published August 23, 2018, application 15/572,308 filed August 12, 2016, US PCT/US2016/056811 filed February 13, 2018, provisional application 62/205,154 filed August 14, 2015, (c) Maidment ADA, Popov AV, Delikatny J, Tsourkas A, Karunamuni R. Al Zaki A, Gavenonis S, Cormode D: Radiographic Contrast Agents for Temporal Subtraction and Dual-Energy X-Ray Imaging, application US-20220265234-A1 published August 25, 2022, application 17/711,156 filed April 1, 2022, division of application 14/776,232 filed on September 14, 2015, now patent 11,337,665, (d) Maidment ADA, Lee B, Ng S, Ringer PA, Kuo J, Acciavatti RJ: Dynamic Four-Dimensional Contrast Enhanced Tomosynthesis, application US-20230240625-A1 published August 3, 2023, application 18/061,928 filed December 5, 2022, continuation of application 15/101,668 filed June 3, 2016, now patent 11,517,270; stock or stock options in Real Time Tomography (spouse, founder and co-owner) and Daimrock (founder and co-owner); receipt of Analogic LMAM-3 detector from Analogic. E.F.C. Grant support from OM1 (Hologic), iCAD, the American Cancer Society, and the Susan G. Komen Breast Cancer Foundation; consulting fees from Hologic and iCad for advisory panel service; payment or honorariar for lectures from iiCME and Medality; travel support for meetings from iiCME and NCoBC; participation on advisory boards for Hologic and iCAD. A.M.M. Grant from the American Cancer Society (PASD-22-1003156-01-PASD). D.K. Support for the present work from the National Institutes of Health (research grant 2R01CA161749), paid to author’s institution; research grants from iCad, GenMab, and Calico, paid to author’s institution; deputy editor for Radiology: Artificial Intelligence.

Figures

None
Graphical abstract
Exclusion flowchart for study patients from March 2011 to December
2014. BI-RADS = Breast Imaging Reporting and Data System, BMI = body mass
index, PD = percent density.
Figure 1:
Exclusion flowchart for study patients from March 2011 to December 2014. BI-RADS = Breast Imaging Reporting and Data System, BMI = body mass index, PD = percent density.
Study design. (A) Data acquisition. (B) Modeling and analysis. (Figure
is simplified, does not include radiomic analysis at different window sizes
and resolutions.) DBT = digital breast tomosynthesis, DM = digital
mammography, 3D = three-dimensional.
Figure 2:
Study design. (A) Data acquisition. (B) Modeling and analysis. (Figure is simplified, does not include radiomic analysis at different window sizes and resolutions.) DBT = digital breast tomosynthesis, DM = digital mammography, 3D = three-dimensional.
Schematic of fully automated three-dimensional lattice-based feature
extraction with window size (W), resolution resampling size (D), and number
of sections (N). The example patient image is a left mediolateral oblique
view from a digital breast tomosynthesis image in a 41-year-old female
patient who was a control.
Figure 3:
Schematic of fully automated three-dimensional lattice-based feature extraction with window size (W), resolution resampling size (D), and number of sections (N). The example patient image is a left mediolateral oblique view from a digital breast tomosynthesis image in a 41-year-old female patient who was a control.
Graph shows C statistics of six different conditional logistic
regression models of cancer risk, for all window sizes and resampling
resolutions, for the six image types analyzed. Vertical bars indicate the
means. BI-RADS = Breast Imaging Reporting and Data System, BMI = body mass
index, DBT = digital breast tomosynthesis, DM = digital mammography, PC =
principal component, PD = percent density, 3D =
three-dimensional.
Figure 4:
Graph shows C statistics of six different conditional logistic regression models of cancer risk, for all window sizes and resampling resolutions, for the six image types analyzed. Vertical bars indicate the means. BI-RADS = Breast Imaging Reporting and Data System, BMI = body mass index, DBT = digital breast tomosynthesis, DM = digital mammography, PC = principal component, PD = percent density, 3D = three-dimensional.
Graph shows C statistics versus resampling resolutions, using the
radiomics-only model (feature principal components 1–10 and no
clinical or demographic covariates), for window size of 12.8 mm, for all
image types. DBT = digital breast tomosynthesis, DM = digital mammography,
3D = three-dimensional.
Figure 5:
Graph shows C statistics versus resampling resolutions, using the radiomics-only model (feature principal components 1–10 and no clinical or demographic covariates), for window size of 12.8 mm, for all image types. DBT = digital breast tomosynthesis, DM = digital mammography, 3D = three-dimensional.
Graphs show C statistics versus resampling resolutions, using the
radiomics-only model (feature principal components 1–10 and no
clinical or demographic covariates), for all window sizes, for image types
(A) raw DM, (B) DBT central projection, processed, and (C) DBT reconstructed
(3D). The lack of obvious trend versus resampling resolution is typical over
all window sizes. DBT = digital breast tomosynthesis, DM = digital
mammography, 3D = three-dimensional.
Figure 6:
Graphs show C statistics versus resampling resolutions, using the radiomics-only model (feature principal components 1–10 and no clinical or demographic covariates), for all window sizes, for image types (A) raw DM, (B) DBT central projection, processed, and (C) DBT reconstructed (3D). The lack of obvious trend versus resampling resolution is typical over all window sizes. DBT = digital breast tomosynthesis, DM = digital mammography, 3D = three-dimensional.
Graph shows P values for likelihood ratio tests of three conditional
logistic regression models of cancer risk, each versus the parallel model
without radiomic information, for all window sizes and resampling
resolutions, for the six image types analyzed. Vertical bars indicate the
means. A lower P value indicates more reason to believe that the model with
radiomic information is a better fit than the parallel model without (low P
value indicates evidence against the null hypothesis that the models with
and without radiomics are equivalent). BI-RADS = Breast Imaging Reporting
and Data System, BMI = body mass index, DBT = digital breast tomosynthesis,
DM = digital mammography, PC = principal component, PD = percent density, 3D
= three-dimensional.
Figure 7:
Graph shows P values for likelihood ratio tests of three conditional logistic regression models of cancer risk, each versus the parallel model without radiomic information, for all window sizes and resampling resolutions, for the six image types analyzed. Vertical bars indicate the means. A lower P value indicates more reason to believe that the model with radiomic information is a better fit than the parallel model without (low P value indicates evidence against the null hypothesis that the models with and without radiomics are equivalent). BI-RADS = Breast Imaging Reporting and Data System, BMI = body mass index, DBT = digital breast tomosynthesis, DM = digital mammography, PC = principal component, PD = percent density, 3D = three-dimensional.

References

    1. Onishi N , Kataoka M . Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies . Breast Cancer 2021. ; 28 ( 6 ): 1195 – 1211 . - PubMed
    1. Saghatchian M , Abehsera M , Yamgnane A , et al . Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic . Breast Cancer Res Treat 2022. ; 192 ( 2 ): 375 – 383 . - PMC - PubMed
    1. Brentnall AR , Cuzick J , Buist DSM , Bowles EJA . Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density . JAMA Oncol 2018. ; 4 ( 9 ): e180174 . - PMC - PubMed
    1. Tirada N , Li G , Dreizin D , et al . Digital Breast Tomosynthesis: Physics, Artifacts, and Quality Control Considerations . RadioGraphics 2019. ; 39 ( 2 ): 413 – 426 . - PubMed
    1. Kerlikowske K , Su YR , Sprague BL , et al . Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer . JAMA 2022. ; 327 ( 22 ): 2220 – 2230 . - PMC - PubMed

Publication types